1 week Ago By ABMN Staff
Chemed Co. ( NYSE:CHE – Get Free Report ) was the target of a large growth in short interest in the month of December. As of December 15th, there was short interest totalling 265,700 shares, a growth of 9.
4% from the November 30th total of 242,800 shares. Based on an average daily trading volume, of 96,300 shares, the short-interest ratio is presently 2.8 days.
Currently, 1.8% of the shares of the company are short sold. Analyst Upgrades and Downgrades Several analysts have weighed in on CHE shares.
Royal Bank of Canada dropped their price objective on shares of Chemed from $697.00 to $633.00 and set an “outperform” rating for the company in a research note on Tuesday, November 5th.
StockNews.com upgraded shares of Chemed from a “hold” rating to a “buy” rating in a research note on Saturday, November 30th. Check Out Our Latest Research Report on CHE Chemed Trading Up 0.
4 % Chemed ( NYSE:CHE – Get Free Report ) last issued its earnings results on Tuesday, October 29th. The company reported $5.64 EPS for the quarter, missing the consensus estimate of $5.
76 by ($0.12). The firm had revenue of $606.
18 million during the quarter, compared to analyst estimates of $612.22 million. Chemed had a net margin of 12.
69% and a return on equity of 27.86%. Chemed’s quarterly revenue was up 7.
4% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $5.32 earnings per share.
On average, research analysts predict that Chemed will post 21.43 EPS for the current fiscal year. Chemed Announces Dividend The business also recently announced a quarterly dividend, which was paid on Friday, December 6th.
Shareholders of record on Monday, November 18th were paid a dividend of $0.50 per share. The ex-dividend date was Monday, November 18th.
This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.38%.
Chemed’s payout ratio is presently 10.11%. Insider Buying and Selling In related news, CEO Kevin J.
Mcnamara sold 2,000 shares of Chemed stock in a transaction dated Monday, November 25th. The shares were sold at an average price of $572.77, for a total transaction of $1,145,540.
00. Following the completion of the sale, the chief executive officer now owns 101,735 shares of the company’s stock, valued at approximately $58,270,755.95.
The trade was a 1.93 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website .
Also, EVP Spencer S. Lee sold 732 shares of Chemed stock in a transaction dated Wednesday, November 27th. The stock was sold at an average price of $575.
62, for a total transaction of $421,353.84. Following the sale, the executive vice president now directly owns 18,287 shares of the company’s stock, valued at $10,526,362.
94. The trade was a 3.85 % decrease in their position.
The disclosure for this sale can be found here . 3.32% of the stock is currently owned by insiders.
Institutional Inflows and Outflows Institutional investors have recently modified their holdings of the stock. American National Bank & Trust bought a new stake in Chemed during the 3rd quarter worth $61,000. GAMMA Investing LLC grew its holdings in shares of Chemed by 60.
5% during the third quarter. GAMMA Investing LLC now owns 138 shares of the company’s stock worth $83,000 after purchasing an additional 52 shares during the last quarter. Quarry LP increased its stake in shares of Chemed by 721.
7% in the second quarter. Quarry LP now owns 189 shares of the company’s stock valued at $103,000 after buying an additional 166 shares during the period. Sound Income Strategies LLC bought a new position in Chemed in the 3rd quarter valued at approximately $201,000.
Finally, Farther Finance Advisors LLC boosted its position in Chemed by 2,314.3% during the 3rd quarter. Farther Finance Advisors LLC now owns 338 shares of the company’s stock worth $203,000 after buying an additional 324 shares during the period.
95.85% of the stock is currently owned by institutional investors and hedge funds. About Chemed ( Get Free Report ) Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States.
The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. Featured Articles Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.
com's FREE daily email newsletter ..
